nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—DRD5—eyelid—Graves' disease	0.43	0.572	CbGeAlD
Apomorphine—CALY—pituitary gland—Graves' disease	0.0702	0.0933	CbGeAlD
Apomorphine—HTR1D—eye—Graves' disease	0.0287	0.0381	CbGeAlD
Apomorphine—HTR1D—connective tissue—Graves' disease	0.0276	0.0367	CbGeAlD
Apomorphine—DRD2—eye—Graves' disease	0.0216	0.0287	CbGeAlD
Apomorphine—HTR2B—adipose tissue—Graves' disease	0.0197	0.0262	CbGeAlD
Apomorphine—HTR2B—thyroid gland—Graves' disease	0.0171	0.0227	CbGeAlD
Apomorphine—ADRA2A—connective tissue—Graves' disease	0.0161	0.0215	CbGeAlD
Apomorphine—DRD2—pituitary gland—Graves' disease	0.016	0.0213	CbGeAlD
Apomorphine—ADRA2C—pituitary gland—Graves' disease	0.0156	0.0207	CbGeAlD
Apomorphine—ADRA2C—adipose tissue—Graves' disease	0.0155	0.0206	CbGeAlD
Apomorphine—HTR2A—eye—Graves' disease	0.0143	0.0189	CbGeAlD
Apomorphine—HTR2A—connective tissue—Graves' disease	0.0137	0.0183	CbGeAlD
Apomorphine—ADRA2A—pituitary gland—Graves' disease	0.0124	0.0165	CbGeAlD
Apomorphine—ADRA2A—adipose tissue—Graves' disease	0.0124	0.0165	CbGeAlD
Apomorphine—Drowsiness—Methimazole—Graves' disease	0.0124	0.106	CcSEcCtD
Apomorphine—ADRA2A—thyroid gland—Graves' disease	0.0107	0.0143	CbGeAlD
Apomorphine—HTR2A—pituitary gland—Graves' disease	0.0106	0.0141	CbGeAlD
Apomorphine—Drowsiness—Propylthiouracil—Graves' disease	0.0105	0.0903	CcSEcCtD
Apomorphine—Arthralgia—Methimazole—Graves' disease	0.00823	0.0707	CcSEcCtD
Apomorphine—Oedema—Methimazole—Graves' disease	0.00789	0.0678	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00719	0.0617	CcSEcCtD
Apomorphine—Somnolence—Methimazole—Graves' disease	0.00702	0.0602	CcSEcCtD
Apomorphine—Arthralgia—Propylthiouracil—Graves' disease	0.007	0.0601	CcSEcCtD
Apomorphine—Oedema—Propylthiouracil—Graves' disease	0.00671	0.0576	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00611	0.0525	CcSEcCtD
Apomorphine—Somnolence—Propylthiouracil—Graves' disease	0.00597	0.0512	CcSEcCtD
Apomorphine—Pruritus—Methimazole—Graves' disease	0.00558	0.0479	CcSEcCtD
Apomorphine—Vomiting—Methimazole—Graves' disease	0.00502	0.0431	CcSEcCtD
Apomorphine—Headache—Methimazole—Graves' disease	0.00494	0.0425	CcSEcCtD
Apomorphine—Pruritus—Propylthiouracil—Graves' disease	0.00475	0.0408	CcSEcCtD
Apomorphine—Nausea—Methimazole—Graves' disease	0.00469	0.0403	CcSEcCtD
Apomorphine—DRD4—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00437	0.0333	CbGpPWpGaD
Apomorphine—Vomiting—Propylthiouracil—Graves' disease	0.00427	0.0366	CcSEcCtD
Apomorphine—Headache—Propylthiouracil—Graves' disease	0.0042	0.0361	CcSEcCtD
Apomorphine—HTR2B—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00418	0.0318	CbGpPWpGaD
Apomorphine—Nausea—Propylthiouracil—Graves' disease	0.00399	0.0342	CcSEcCtD
Apomorphine—DRD1—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00394	0.03	CbGpPWpGaD
Apomorphine—DRD3—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00388	0.0296	CbGpPWpGaD
Apomorphine—ADRA1D—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00388	0.0296	CbGpPWpGaD
Apomorphine—ADRA2B—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00351	0.0267	CbGpPWpGaD
Apomorphine—HTR1A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00339	0.0258	CbGpPWpGaD
Apomorphine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00337	0.0256	CbGpPWpGaD
Apomorphine—ADRA2C—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00328	0.0249	CbGpPWpGaD
Apomorphine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00322	0.0245	CbGpPWpGaD
Apomorphine—DRD2—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00297	0.0226	CbGpPWpGaD
Apomorphine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00292	0.0223	CbGpPWpGaD
Apomorphine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00266	0.0203	CbGpPWpGaD
Apomorphine—DRD5—G alpha (s) signalling events—TSHR—Graves' disease	0.00226	0.0172	CbGpPWpGaD
Apomorphine—DRD1—G alpha (s) signalling events—TSHR—Graves' disease	0.0015	0.0114	CbGpPWpGaD
Apomorphine—DRD5—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00108	0.00821	CbGpPWpGaD
Apomorphine—HTR1D—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000827	0.00629	CbGpPWpGaD
Apomorphine—DRD5—GPCR ligand binding—TSHR—Graves' disease	0.000822	0.00626	CbGpPWpGaD
Apomorphine—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000809	0.00616	CbGpPWpGaD
Apomorphine—DRD4—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000797	0.00606	CbGpPWpGaD
Apomorphine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00076	0.00579	CbGpPWpGaD
Apomorphine—DRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000717	0.00546	CbGpPWpGaD
Apomorphine—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000708	0.00539	CbGpPWpGaD
Apomorphine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000708	0.00539	CbGpPWpGaD
Apomorphine—DRD5—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000697	0.00531	CbGpPWpGaD
Apomorphine—HTR1D—G alpha (i) signalling events—CXCL10—Graves' disease	0.000672	0.00511	CbGpPWpGaD
Apomorphine—HTR1B—G alpha (i) signalling events—CXCL10—Graves' disease	0.000658	0.00501	CbGpPWpGaD
Apomorphine—DRD4—G alpha (i) signalling events—CXCL10—Graves' disease	0.000647	0.00493	CbGpPWpGaD
Apomorphine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000639	0.00486	CbGpPWpGaD
Apomorphine—HTR1D—GPCR ligand binding—TSHR—Graves' disease	0.00063	0.00479	CbGpPWpGaD
Apomorphine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000617	0.00469	CbGpPWpGaD
Apomorphine—HTR1B—GPCR ligand binding—TSHR—Graves' disease	0.000616	0.00469	CbGpPWpGaD
Apomorphine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000613	0.00467	CbGpPWpGaD
Apomorphine—DRD4—GPCR ligand binding—TSHR—Graves' disease	0.000607	0.00462	CbGpPWpGaD
Apomorphine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000597	0.00454	CbGpPWpGaD
Apomorphine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000587	0.00447	CbGpPWpGaD
Apomorphine—HTR2B—GPCR ligand binding—TSHR—Graves' disease	0.000579	0.00441	CbGpPWpGaD
Apomorphine—DRD3—G alpha (i) signalling events—CXCL10—Graves' disease	0.000575	0.00438	CbGpPWpGaD
Apomorphine—DRD4—Circadian rythm related genes—FAS—Graves' disease	0.000564	0.00429	CbGpPWpGaD
Apomorphine—DRD1—GPCR ligand binding—TSHR—Graves' disease	0.000546	0.00416	CbGpPWpGaD
Apomorphine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000541	0.00412	CbGpPWpGaD
Apomorphine—DRD3—GPCR ligand binding—TSHR—Graves' disease	0.000539	0.0041	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR ligand binding—TSHR—Graves' disease	0.000539	0.0041	CbGpPWpGaD
Apomorphine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000534	0.00407	CbGpPWpGaD
Apomorphine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000533	0.00405	CbGpPWpGaD
Apomorphine—DRD5—GPCR ligand binding—CXCL10—Graves' disease	0.000531	0.00404	CbGpPWpGaD
Apomorphine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000523	0.00398	CbGpPWpGaD
Apomorphine—ADRA2B—G alpha (i) signalling events—CXCL10—Graves' disease	0.000519	0.00395	CbGpPWpGaD
Apomorphine—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000515	0.00392	CbGpPWpGaD
Apomorphine—DRD1—Circadian rythm related genes—FAS—Graves' disease	0.000508	0.00386	CbGpPWpGaD
Apomorphine—HTR1A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000501	0.00381	CbGpPWpGaD
Apomorphine—DRD3—Circadian rythm related genes—FAS—Graves' disease	0.000501	0.00381	CbGpPWpGaD
Apomorphine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000491	0.00374	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR ligand binding—TSHR—Graves' disease	0.000486	0.0037	CbGpPWpGaD
Apomorphine—ADRA2C—G alpha (i) signalling events—CXCL10—Graves' disease	0.000485	0.00369	CbGpPWpGaD
Apomorphine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000485	0.00369	CbGpPWpGaD
Apomorphine—HTR1A—GPCR ligand binding—TSHR—Graves' disease	0.00047	0.00357	CbGpPWpGaD
Apomorphine—HTR2C—GPCR ligand binding—TSHR—Graves' disease	0.000467	0.00356	CbGpPWpGaD
Apomorphine—DRD5—GPCR downstream signaling—TSHR—Graves' disease	0.000464	0.00354	CbGpPWpGaD
Apomorphine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000463	0.00353	CbGpPWpGaD
Apomorphine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000457	0.00348	CbGpPWpGaD
Apomorphine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000457	0.00348	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR ligand binding—TSHR—Graves' disease	0.000454	0.00346	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR ligand binding—TSHR—Graves' disease	0.000447	0.0034	CbGpPWpGaD
Apomorphine—DRD2—G alpha (i) signalling events—CXCL10—Graves' disease	0.00044	0.00335	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—TSHR—Graves' disease	0.000422	0.00321	CbGpPWpGaD
Apomorphine—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000417	0.00317	CbGpPWpGaD
Apomorphine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000413	0.00314	CbGpPWpGaD
Apomorphine—DRD2—GPCR ligand binding—TSHR—Graves' disease	0.000412	0.00314	CbGpPWpGaD
Apomorphine—HTR1D—GPCR ligand binding—CXCL10—Graves' disease	0.000407	0.0031	CbGpPWpGaD
Apomorphine—HTR2A—GPCR ligand binding—TSHR—Graves' disease	0.000406	0.00309	CbGpPWpGaD
Apomorphine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000398	0.00303	CbGpPWpGaD
Apomorphine—HTR1B—GPCR ligand binding—CXCL10—Graves' disease	0.000398	0.00303	CbGpPWpGaD
Apomorphine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000396	0.00302	CbGpPWpGaD
Apomorphine—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000394	0.003	CbGpPWpGaD
Apomorphine—DRD4—GPCR ligand binding—CXCL10—Graves' disease	0.000392	0.00298	CbGpPWpGaD
Apomorphine—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000389	0.00296	CbGpPWpGaD
Apomorphine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000386	0.00293	CbGpPWpGaD
Apomorphine—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.000383	0.00292	CbGpPWpGaD
Apomorphine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000379	0.00289	CbGpPWpGaD
Apomorphine—HTR2B—GPCR ligand binding—CXCL10—Graves' disease	0.000374	0.00285	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.000369	0.00281	CbGpPWpGaD
Apomorphine—HTR1D—GPCR downstream signaling—TSHR—Graves' disease	0.000356	0.00271	CbGpPWpGaD
Apomorphine—DRD1—GPCR ligand binding—CXCL10—Graves' disease	0.000353	0.00269	CbGpPWpGaD
Apomorphine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00035	0.00266	CbGpPWpGaD
Apomorphine—HTR1B—GPCR downstream signaling—TSHR—Graves' disease	0.000348	0.00265	CbGpPWpGaD
Apomorphine—DRD3—GPCR ligand binding—CXCL10—Graves' disease	0.000348	0.00265	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR ligand binding—CXCL10—Graves' disease	0.000348	0.00265	CbGpPWpGaD
Apomorphine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000344	0.00262	CbGpPWpGaD
Apomorphine—DRD4—GPCR downstream signaling—TSHR—Graves' disease	0.000343	0.00261	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—TSHR—Graves' disease	0.000327	0.00249	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—TSHR—Graves' disease	0.000323	0.00246	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—TSHR—Graves' disease	0.000316	0.00241	CbGpPWpGaD
Apomorphine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000316	0.00241	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	0.000314	0.00239	CbGpPWpGaD
Apomorphine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000313	0.00238	CbGpPWpGaD
Apomorphine—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000313	0.00238	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—TSHR—Graves' disease	0.000311	0.00237	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—TSHR—Graves' disease	0.000309	0.00235	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—TSHR—Graves' disease	0.000304	0.00232	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—TSHR—Graves' disease	0.000304	0.00232	CbGpPWpGaD
Apomorphine—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.000303	0.00231	CbGpPWpGaD
Apomorphine—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000302	0.0023	CbGpPWpGaD
Apomorphine—DRD5—GPCR downstream signaling—CXCL10—Graves' disease	0.0003	0.00228	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—TSHR—Graves' disease	0.000297	0.00226	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	0.000294	0.00223	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	0.000289	0.0022	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—TSHR—Graves' disease	0.00028	0.00213	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—TSHR—Graves' disease	0.000276	0.0021	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—TSHR—Graves' disease	0.000276	0.0021	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	0.000275	0.00209	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—CXCL10—Graves' disease	0.000273	0.00207	CbGpPWpGaD
Apomorphine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.00027	0.00206	CbGpPWpGaD
Apomorphine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000266	0.00203	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000265	0.00202	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.000264	0.00201	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—GC—Graves' disease	0.000262	0.002	CbGpPWpGaD
Apomorphine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000262	0.002	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	0.000257	0.00195	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	0.000253	0.00192	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	0.00025	0.0019	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TSHR—Graves' disease	0.000249	0.0019	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	0.000241	0.00183	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	0.00024	0.00182	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.000238	0.00182	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	0.000233	0.00177	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	0.000233	0.00177	CbGpPWpGaD
Apomorphine—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	0.00023	0.00175	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	0.000229	0.00175	CbGpPWpGaD
Apomorphine—DRD5—GPCR downstream signaling—IL2RA—Graves' disease	0.000229	0.00175	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	0.000229	0.00174	CbGpPWpGaD
Apomorphine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000227	0.00173	CbGpPWpGaD
Apomorphine—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000225	0.00171	CbGpPWpGaD
Apomorphine—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	0.000222	0.00169	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—IL2RA—Graves' disease	0.000215	0.00164	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—GC—Graves' disease	0.000213	0.00162	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—TSHR—Graves' disease	0.000212	0.00161	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000211	0.00161	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	0.000209	0.00159	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	0.000209	0.00159	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—IL2RA—Graves' disease	0.000208	0.00159	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	0.000208	0.00158	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	0.000204	0.00156	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—CXCL10—Graves' disease	0.000201	0.00153	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—IL2RA—Graves' disease	0.000201	0.00153	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	0.000199	0.00152	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—B3GNT2—Graves' disease	0.000199	0.00151	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	0.000197	0.0015	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000197	0.0015	CbGpPWpGaD
Apomorphine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000196	0.00149	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	0.000192	0.00146	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TSHR—Graves' disease	0.000191	0.00145	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	0.000189	0.00144	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TSHR—Graves' disease	0.000187	0.00142	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TSHR—Graves' disease	0.000184	0.0014	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—CXCL10—Graves' disease	0.000181	0.00138	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—CXCL10—Graves' disease	0.000179	0.00136	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—CXCL10—Graves' disease	0.000179	0.00136	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000178	0.00135	CbGpPWpGaD
Apomorphine—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	0.000176	0.00134	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TSHR—Graves' disease	0.000176	0.00134	CbGpPWpGaD
Apomorphine—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000172	0.00131	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000171	0.00131	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000171	0.0013	CbGpPWpGaD
Apomorphine—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	0.000169	0.00129	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000166	0.00126	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TSHR—Graves' disease	0.000166	0.00126	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TSHR—Graves' disease	0.000163	0.00124	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TSHR—Graves' disease	0.000163	0.00124	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000163	0.00124	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—IL2RA—Graves' disease	0.000163	0.00124	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	0.000162	0.00123	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—B3GNT2—Graves' disease	0.000161	0.00123	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	0.000161	0.00123	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CXCL10—Graves' disease	0.000161	0.00123	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	0.00016	0.00121	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	0.000156	0.00119	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	0.000156	0.00119	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	0.000155	0.00118	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—IL2RA—Graves' disease	0.000154	0.00117	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	0.000152	0.00116	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	0.000151	0.00115	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	0.000151	0.00115	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—IL2RA—Graves' disease	0.00015	0.00114	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	0.00015	0.00114	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	0.000148	0.00113	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000148	0.00113	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TSHR—Graves' disease	0.000147	0.00112	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	0.000147	0.00112	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TSHR—Graves' disease	0.000142	0.00108	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TSHR—Graves' disease	0.000142	0.00108	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL2RA—Graves' disease	0.000138	0.00105	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TSHR—Graves' disease	0.000138	0.00105	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	0.000137	0.00104	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL2RA—Graves' disease	0.000137	0.00104	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL2RA—Graves' disease	0.000137	0.00104	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	0.000136	0.00103	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TSHR—Graves' disease	0.000136	0.00103	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000135	0.00103	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	0.000135	0.00102	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000131	0.000998	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	0.00013	0.000992	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	0.000127	0.000965	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TSHR—Graves' disease	0.000125	0.000951	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000125	0.00095	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CXCL10—Graves' disease	0.000123	0.000939	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	0.000123	0.000938	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL2RA—Graves' disease	0.000123	0.000937	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TSHR—Graves' disease	0.000123	0.000936	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	0.000122	0.000932	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CXCL10—Graves' disease	0.000121	0.000919	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	0.000119	0.000906	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CXCL10—Graves' disease	0.000119	0.000904	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	0.000118	0.000901	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	0.000115	0.000877	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	0.000115	0.000876	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CXCL10—Graves' disease	0.000113	0.000863	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	0.000113	0.000863	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	0.000113	0.000862	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	0.000112	0.000852	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CXCL10—Graves' disease	0.000107	0.000814	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CXCL10—Graves' disease	0.000106	0.000803	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CXCL10—Graves' disease	0.000106	0.000803	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	0.000104	0.000795	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	0.000103	0.000784	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	0.000103	0.000783	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	9.53e-05	0.000725	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL2RA—Graves' disease	9.43e-05	0.000717	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	9.35e-05	0.000712	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL2RA—Graves' disease	9.23e-05	0.000703	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	9.2e-05	0.0007	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	9.15e-05	0.000697	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL2RA—Graves' disease	9.08e-05	0.000691	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	8.9e-05	0.000678	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	8.76e-05	0.000667	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL2RA—Graves' disease	8.67e-05	0.00066	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL2RA—Graves' disease	8.18e-05	0.000622	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL10—Graves' disease	8.08e-05	0.000615	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL2RA—Graves' disease	8.07e-05	0.000614	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL2RA—Graves' disease	8.07e-05	0.000614	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	7.95e-05	0.000605	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	7.28e-05	0.000554	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	7.23e-05	0.00055	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	7.03e-05	0.000535	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	6.99e-05	0.000532	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	6.8e-05	0.000518	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	6.7e-05	0.00051	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL2RA—Graves' disease	6.17e-05	0.00047	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	6.07e-05	0.000462	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	5.53e-05	0.000421	CbGpPWpGaD
